Gary Bouloux, MD
Oral & Maxillofacial Surgery · Atlanta, GANPI 1750335733
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 66.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $8,300 and has fallen 91.4% since, to $718 in 2025. Among oral & maxillofacial surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $251.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Stryker$3K
- Kls-martin L.p.$1K
- Kerecis Limited$102
Across 2 payments — averaging $5264.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$11K
What the payments were for
- Consulting fees$5,25044%
- Travel & lodging$3,70131%
- Food & beverage$2,87924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $7,893 |
| Stryker | 24 | $2,532 |
| Kls-martin L.p. | 12 | $1,303 |
| Kerecis Limited | 1 | $102 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$7,694
- NA$1,111
- PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM$777
- Kerecis SurgiClose$409
- Kerecis GraftGuide$102
How this compares
$11,830 in reported general payments places this provider in the 95th percentile of 236 oral & maxillofacial surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 42 | $1,075 |
| Chlorhexidine Gluconate | 201 | $1,016 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $646 |
| Amoxicillin | 122 | $435 |
| Baclofen | 41 | $366 |
| Ketorolac Tromethamine | 20 | $255 |
| Oxycodone Hcl | 72 | $199 |
| Ibuprofen | 54 | $171 |
| Clindamycin Hcl | 16 | $153 |
| Gabapentin | 11 | $121 |
| Cephalexin | 19 | $105 |
| Meloxicam | 22 | $71 |
| Tramadol Hcl | 19 | $25 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Atlanta
- Dina AminAtlanta$21K
- Steven RoserAtlanta$11K
- Thomas BerryAtlanta$5K
- Stephanie DrewAtlanta$4K
- Hari DigumarthiAtlanta$3K
- Salam SalmanCalhoun$60K
- Jay ReznickWoodstock$51K
- Paul SchanerMarietta$42K
- Ryan SemensohnBrookhaven$39K
- Raymond DickeyDallas$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.